Oligodendroglioma patient survival is associated with circulating B-cells and age.
Jennie W TaylorGayathri WarrierHelen M HansenLucie McCoyTerri RiceGeno A GuerraStephen S FrancisJennifer L ClarkePaige M BracciSara HadadKarl T KelseyMargaret WrenschAnnette M MolinaroJohn K WienckePublished in: Neuro-oncology advances (2024)
Peripheral blood immune profiles in oligodendroglioma suggested that younger patients with lower B-naïve cells experienced shorter survival. Though our findings lack of validation cohort and use a heterogenous patient population, they suggest peripheral blood immune profiles may be prognostic for patients with glioma and warrant further investigation.